Katalin Balassa - Concepedia

Author

Katalin Balassa

Unified Szent István and Szent László Hospital ORCID

Also Known As

K Balassa, K. Balassa, Katalin Balassa

Publications

389

Citations

H-Index

Concepts

All Affiliations

Unified Szent István and Szent László Hospital Hungarian National Blood Transfusion Service Semmelweis University NHS Blood and Transplant Oxford University Hospitals NHS Trust

About

Katalin Balassa is an author at Unified Szent István and Szent László Hospital specializing in medicine, hematology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	144
2	Health Sciences	3	3	131
3	Blood Transplantation	1	1	21
4	Cell Biology	1	1	21
5	Cellular Therapies	1	1	21

Katalin Balassa

Publications

193

Citations

H-Index

Page 1

	Year	Citations
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations Hajnalka Andrikovics, Tünde Krähling, Katalin Balassa, Haematologica Somatic Insertions/deletionsHematological MalignancyCalreticulin MutationsCalreticulin Mutational LoadMedicine	2014	98
Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common <i>TERT</i> Polymorphism rs2736100 Tünde Krähling, Katalin Balassa, Katalin Piroska Kiss, Cancer Epidemiology Biomarkers & Prevention	2015	24
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy Katalin Balassa, Hajnalka Andrikovics, Péter Reményi, Bone Marrow Transplantation Cell TherapyTransplantationMarrow TransplantationMedicineStem Cell Transplantation	2015	21
Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation Katalin Balassa, Richard Anthony Salisbury, Edmund Watson, Journal of Infection Viral ReplicationTransplantationViral PersistenceViral PathogenesisVirology	2019	13
Attrition at the final donor stage among unrelated haematopoietic stem cell donors: the British Bone Marrow Registry experience Katalin Balassa, Angharad Griffiths, David Winstone, Transfusion Medicine	2019	13
<i><scp>NFKB</scp>1 −</i>94ins/del<scp>ATTG</scp> polymorphism is a novel prognostic marker in first line‐treated multiple myeloma Gergely Varga, Gábor Mikala, Hajnalka Andrikovics, British Journal of Haematology	2014	12
Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple Myeloma Gergely Varga, Gábor Mikala, Katalin Piroska Kiss, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyP11a PolymorphismNew Prognostic MarkerMedicineHematology	2017	12

Page 1